56 related articles for article (PubMed ID: 25691284)
1. Development and validation of a prediction model for loss of physical function in elderly hemodialysis patients.
Fukuma S; Shimizu S; Shintani A; Kamitani T; Akizawa T; Fukuhara S
Nephrol Dial Transplant; 2018 Aug; 33(8):1452-1458. PubMed ID: 28992129
[TBL] [Abstract][Full Text] [Related]
2. History of fragility fracture is associated with cardiovascular mortality in hemodialysis patients: the Q-Cohort study.
Haruyama N; Nakayama M; Yamada S; Tanaka S; Hiyamuta H; Taniguchi M; Tokumoto M; Tsuruya K; Kitazono T; Nakano T
J Bone Miner Metab; 2024 Mar; 42(2):253-263. PubMed ID: 38509305
[TBL] [Abstract][Full Text] [Related]
3. Resistance to Erythropoiesis-Stimulating Agents in Pre-Dialysis and Post-Dialysis Mortality in Japanese Incident Hemodialysis Patients.
Hayashi T; Joki N; Tanaka Y; Iwasaki M; Kubo S; Matsukane A; Takahashi Y; Imamura Y; Hirahata K; Hase H
Blood Purif; 2019; 47 Suppl 2(Suppl 1):31-37. PubMed ID: 30943479
[TBL] [Abstract][Full Text] [Related]
4. Role of Fracture Risk Assessment Tool and Bone Turnover Markers in Predicting All-Cause and Cardiovascular Mortality in Hemodialysis Patients.
Wu PY; Chen SC; Lin YC; Chen PC; Chung WS; Huang YC; Wu PH; Tsai YC; Huang JC; Chiu YW; Chang JM
Front Med (Lausanne); 2022; 9():891363. PubMed ID: 35463031
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and predictors of asymptomatic vertebral fracture in patients with end-stage renal disease.
Jirasirirak S; Disthabanchong S; Ongphiphadhanakul B; Arj-Ong Vallibhakara S; Nimitphong H
Heliyon; 2022 Mar; 8(3):e09158. PubMed ID: 35368525
[TBL] [Abstract][Full Text] [Related]
6. Molecular Abnormalities Underlying Bone Fragility in Chronic Kidney Disease.
Iwasaki Y; Kazama JJ; Fukagawa M
Biomed Res Int; 2017; 2017():3485785. PubMed ID: 28421193
[TBL] [Abstract][Full Text] [Related]
7. Osteoprotegerin and uremic osteoporosis in chronic hemodialysis patients.
Moldovan D; Rusu C; Potra A; Moldovan I; Patiu IM; Gherman-Caprioara M; Kacso IM
Int Urol Nephrol; 2017 May; 49(5):895-901. PubMed ID: 28161839
[TBL] [Abstract][Full Text] [Related]
8. Chronic kidney disease and fragility fracture.
Kazama JJ
Clin Exp Nephrol; 2017 Mar; 21(Suppl 1):46-52. PubMed ID: 28012057
[TBL] [Abstract][Full Text] [Related]
9. Not only for the risk of bone fracture.
Fukagawa M
J Bone Miner Metab; 2015 Nov; 33(6):603-4. PubMed ID: 25959644
[No Abstract] [Full Text] [Related]
10. The added value of trabecular bone score to FRAX® to predict major osteoporotic fractures for clinical use in Chinese older people: the Mr. OS and Ms. OS cohort study in Hong Kong.
Su Y; Leung J; Hans D; Lamy O; Kwok T
Osteoporos Int; 2017 Jan; 28(1):111-117. PubMed ID: 27565645
[TBL] [Abstract][Full Text] [Related]
11. [Epidemiology of bone and joint disease - the present and future - . Epidemiology of osteoporosis and osteoporotic fracture in Japan].
Iki M
Clin Calcium; 2014 May; 24(5):657-64. PubMed ID: 24769675
[TBL] [Abstract][Full Text] [Related]
12. The FRAX ® as a predictor of mortality in Japanese incident hemodialysis patients: an observational, follow-up study.
Hayashi T; Joki N; Tanaka Y; Iwasaki M; Kubo S; Asakawa T; Matsukane A; Takahashi Y; Imamura Y; Hirahata K; Hase H
J Bone Miner Metab; 2015 Nov; 33(6):674-83. PubMed ID: 25691284
[TBL] [Abstract][Full Text] [Related]
13. Fracture risk prediction using FRAX®: a 10-year follow-up survey of the Japanese Population-Based Osteoporosis (JPOS) Cohort Study.
Tamaki J; Iki M; Kadowaki E; Sato Y; Kajita E; Kagamimori S; Kagawa Y; Yoneshima H
Osteoporos Int; 2011 Dec; 22(12):3037-45. PubMed ID: 21279504
[TBL] [Abstract][Full Text] [Related]
14. The utility of FRAX® in predicting bone fractures in patients with chronic kidney disease on hemodialysis: a two-year prospective multicenter cohort study.
Przedlacki J; Buczyńska-Chyl J; Koźmiński P; Niemczyk E; Wojtaszek E; Gieglis E; Żebrowski P; Podgórzak A; Wściślak J; Wieliczko M; Matuszkiewicz-Rowińska J;
Osteoporos Int; 2018 May; 29(5):1105-1115. PubMed ID: 29411069
[TBL] [Abstract][Full Text] [Related]
15. Fracture prediction and calibration of a Canadian FRAX® tool: a population-based report from CaMos.
Fraser LA; Langsetmo L; Berger C; Ioannidis G; Goltzman D; Adachi JD; Papaioannou A; Josse R; Kovacs CS; Olszynski WP; Towheed T; Hanley DA; Kaiser SM; Prior J; Jamal S; Kreiger N; Brown JP; Johansson H; Oden A; McCloskey E; Kanis JA; Leslie WD;
Osteoporos Int; 2011 Mar; 22(3):829-37. PubMed ID: 21161508
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
